Brochure
Therapeutic proteins and monoclonal antibodies (MAb) have transformed biotechnology and the pharmaceutical industry. Together they form the largest part of the rapidly growing biologics drug market. Protein-based drugs include blood factors, thrombolytic agents, hormones, hematopoietic growth factors, interferons, interleukins, tumor necrosis factor, and therapeutic enzymes.
Essential to the development of biotherapeutics is ability to quickly and accurately assess product quality and safety—including factors such as sequence integrity, glycan heterogeneity, and purity—at each step. Thermo Scientific workflows for intact-protein analysis enable these assessments early in the development process without the effort of complete characterization. Our workflows can provide insights that allow you to make better, faster decisions about how to proceed with your biotherapeutic development.
Thermo Fisher Scientific
United States
